Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (561-570 of 933) with videos related to

Pageof 94
Sort By:
The American Journal of Surgical Pathology|October 25, 2016
Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and MyopericytomasAbbas Agaimy, Matthias Bieg, Michael Michal, et al.
International Journal of Cancer|November 1, 2013
The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancerAkin Atmaca, Salah-Eddin Al-Batran, Ralph Markus Wirtz, et al.
International Journal of Molecular Sciences|November 13, 2020
High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder CancerSabine Hülsen, Eleonora Lippolis, Fulvia Ferrazzi, et al.
Diagnostic Pathology|June 18, 2014
KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE)Lothar Veits, Rupert Schupfner, Petra Hufnagel, et al.
International Journal of Molecular Sciences|February 25, 2023
Anti-DNA-IgM Favors the Detection of NET-Associated Extracellular DNAHan Wang, Antonia Margarethe Stehr, Jeeshan Singh, et al.
Archives of Medical Science : AMS|February 28, 2024
Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single centerDimitrios Raptis, Matthias Maak, Christian Krautz, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 1, 2010
Mutational activation of FGFR3 is not involved in the development of prostate cancerStella Koufou, Jens-Claudio Lunz, Albert Borchardt, et al.
Cancers|May 21, 2020
CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node StageMarkus Eckstein, Elena Epple, Rudolf Jung, et al.
European Urology Open Science|June 16, 2025
Clinical and Genomic Landscape of <i>FGFR3</i> Alterations Across Different Stages of Urothelial CancerMaximilian Haas, Roman Mayr, Danijel Sikic, et al.
Cancers|September 19, 2020
Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer PatientsPaul König, Markus Eckstein, Rudolf Jung, et al.
Pageof 94

Showing results (561-570 of 933) with videos related to

Sort By:
Pageof 94
The American Journal of Surgical Pathology|October 25, 2016
Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and MyopericytomasAbbas Agaimy, Matthias Bieg, Michael Michal, et al.
International Journal of Cancer|November 1, 2013
The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancerAkin Atmaca, Salah-Eddin Al-Batran, Ralph Markus Wirtz, et al.
International Journal of Molecular Sciences|November 13, 2020
High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder CancerSabine Hülsen, Eleonora Lippolis, Fulvia Ferrazzi, et al.
Diagnostic Pathology|June 18, 2014
KRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE)Lothar Veits, Rupert Schupfner, Petra Hufnagel, et al.
International Journal of Molecular Sciences|February 25, 2023
Anti-DNA-IgM Favors the Detection of NET-Associated Extracellular DNAHan Wang, Antonia Margarethe Stehr, Jeeshan Singh, et al.
Archives of Medical Science : AMS|February 28, 2024
Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single centerDimitrios Raptis, Matthias Maak, Christian Krautz, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 1, 2010
Mutational activation of FGFR3 is not involved in the development of prostate cancerStella Koufou, Jens-Claudio Lunz, Albert Borchardt, et al.
Cancers|May 21, 2020
CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node StageMarkus Eckstein, Elena Epple, Rudolf Jung, et al.
European Urology Open Science|June 16, 2025
Clinical and Genomic Landscape of <i>FGFR3</i> Alterations Across Different Stages of Urothelial CancerMaximilian Haas, Roman Mayr, Danijel Sikic, et al.
Cancers|September 19, 2020
Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer PatientsPaul König, Markus Eckstein, Rudolf Jung, et al.
Pageof 94